nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Prednisone—prostate cancer	0.237	1	CrCtD
Fludrocortisone—AR—prostate cancer	0.113	0.596	CbGaD
Fludrocortisone—NR3C1—prostate cancer	0.0764	0.404	CbGaD
Fludrocortisone—AR—Nilutamide—prostate cancer	0.0723	0.298	CbGbCtD
Fludrocortisone—AR—Bicalutamide—prostate cancer	0.0723	0.298	CbGbCtD
Fludrocortisone—AR—Flutamide—prostate cancer	0.0599	0.247	CbGbCtD
Fludrocortisone—Testosterone—Abiraterone—prostate cancer	0.0456	0.213	CrCrCtD
Fludrocortisone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0256	0.12	CrCrCtD
Fludrocortisone—AR—Estradiol—prostate cancer	0.0249	0.102	CbGbCtD
Fludrocortisone—Testosterone—Estramustine—prostate cancer	0.0189	0.0884	CrCrCtD
Fludrocortisone—Testosterone—Estrone—prostate cancer	0.015	0.0702	CrCrCtD
Fludrocortisone—NR3C1—Prednisone—prostate cancer	0.0136	0.056	CbGbCtD
Fludrocortisone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0125	0.0584	CrCrCtD
Fludrocortisone—Testosterone—Estradiol—prostate cancer	0.0114	0.0532	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—prostate cancer	0.00727	0.034	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—prostate cancer	0.00534	0.025	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—prostate cancer	0.00518	0.0242	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—prostate cancer	0.00462	0.0216	CrCrCtD
Fludrocortisone—Desonide—Prednisone—prostate cancer	0.0045	0.021	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—prostate cancer	0.0045	0.021	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—prostate cancer	0.0045	0.021	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—prostate cancer	0.00439	0.0205	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—prostate cancer	0.00428	0.02	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—prostate cancer	0.00418	0.0195	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00418	0.0195	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—prostate cancer	0.00418	0.0195	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—prostate cancer	0.00418	0.0195	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—prostate cancer	0.00418	0.0195	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—prostate cancer	0.00408	0.0191	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—prostate cancer	0.00408	0.0191	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—prostate cancer	0.0039	0.0182	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—prostate cancer	0.00382	0.0179	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—prostate cancer	0.00367	0.0171	CrCrCtD
Fludrocortisone—AR—penis—prostate cancer	0.00305	0.174	CbGeAlD
Fludrocortisone—AR—semen—prostate cancer	0.00291	0.166	CbGeAlD
Fludrocortisone—NR3C1—urine—prostate cancer	0.00147	0.0841	CbGeAlD
Fludrocortisone—NR3C2—prostate gland—prostate cancer	0.000984	0.0563	CbGeAlD
Fludrocortisone—NR3C2—seminal vesicle—prostate cancer	0.000833	0.0476	CbGeAlD
Fludrocortisone—AR—prostate gland—prostate cancer	0.000729	0.0417	CbGeAlD
Fludrocortisone—NR3C2—renal system—prostate cancer	0.000671	0.0383	CbGeAlD
Fludrocortisone—NR3C2—urethra—prostate cancer	0.000659	0.0377	CbGeAlD
Fludrocortisone—AR—seminal vesicle—prostate cancer	0.000617	0.0352	CbGeAlD
Fludrocortisone—AR—epithelium—prostate cancer	0.000536	0.0306	CbGeAlD
Fludrocortisone—NR3C1—prostate gland—prostate cancer	0.000528	0.0302	CbGeAlD
Fludrocortisone—AR—renal system—prostate cancer	0.000497	0.0284	CbGeAlD
Fludrocortisone—AR—urethra—prostate cancer	0.000488	0.0279	CbGeAlD
Fludrocortisone—NR3C1—seminal vesicle—prostate cancer	0.000447	0.0255	CbGeAlD
Fludrocortisone—NR3C2—testis—prostate cancer	0.000434	0.0248	CbGeAlD
Fludrocortisone—NR3C1—epithelium—prostate cancer	0.000388	0.0222	CbGeAlD
Fludrocortisone—NR3C1—renal system—prostate cancer	0.00036	0.0206	CbGeAlD
Fludrocortisone—NR3C1—urethra—prostate cancer	0.000354	0.0202	CbGeAlD
Fludrocortisone—AR—testis—prostate cancer	0.000321	0.0184	CbGeAlD
Fludrocortisone—NR3C2—lymph node—prostate cancer	0.000314	0.018	CbGeAlD
Fludrocortisone—NR3C1—bone marrow—prostate cancer	0.000272	0.0156	CbGeAlD
Fludrocortisone—AR—lymph node—prostate cancer	0.000233	0.0133	CbGeAlD
Fludrocortisone—NR3C1—testis—prostate cancer	0.000233	0.0133	CbGeAlD
Fludrocortisone—NR3C1—lymph node—prostate cancer	0.000169	0.00964	CbGeAlD
Fludrocortisone—Amcinonide—ANXA1—prostate cancer	0.000134	0.0559	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.00011	0.046	CrCbGaD
Fludrocortisone—Hypersensitivity—Degarelix—prostate cancer	7.6e-05	0.0012	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Bicalutamide—prostate cancer	7.59e-05	0.0012	CcSEcCtD
Fludrocortisone—Oesophagitis—Docetaxel—prostate cancer	7.58e-05	0.00119	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—prostate cancer	7.56e-05	0.00119	CcSEcCtD
Fludrocortisone—Insomnia—Bicalutamide—prostate cancer	7.54e-05	0.00119	CcSEcCtD
Fludrocortisone—Cataract—Prednisone—prostate cancer	7.52e-05	0.00118	CcSEcCtD
Fludrocortisone—Neoplasm—Docetaxel—prostate cancer	7.5e-05	0.00118	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—prostate cancer	7.49e-05	0.00118	CcSEcCtD
Fludrocortisone—Asthenia—Degarelix—prostate cancer	7.4e-05	0.00117	CcSEcCtD
Fludrocortisone—Oesophagitis—Capecitabine—prostate cancer	7.34e-05	0.00116	CcSEcCtD
Fludrocortisone—Sweating increased—Mitoxantrone—prostate cancer	7.34e-05	0.00116	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Estradiol—prostate cancer	7.29e-05	0.00115	CcSEcCtD
Fludrocortisone—Neoplasm—Capecitabine—prostate cancer	7.26e-05	0.00114	CcSEcCtD
Fludrocortisone—Ecchymosis—Capecitabine—prostate cancer	7.26e-05	0.00114	CcSEcCtD
Fludrocortisone—Headache—Nilutamide—prostate cancer	7.23e-05	0.00114	CcSEcCtD
Fludrocortisone—Headache—Flutamide—prostate cancer	7.2e-05	0.00113	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cabazitaxel—prostate cancer	7.16e-05	0.00113	CcSEcCtD
Fludrocortisone—Erythema—Goserelin—prostate cancer	7.1e-05	0.00112	CcSEcCtD
Fludrocortisone—Oedema—Ethinyl Estradiol—prostate cancer	7.04e-05	0.00111	CcSEcCtD
Fludrocortisone—Erythema—Conjugated Estrogens—prostate cancer	7.04e-05	0.00111	CcSEcCtD
Fludrocortisone—Infection—Ethinyl Estradiol—prostate cancer	7e-05	0.0011	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—prostate cancer	7e-05	0.0011	CcSEcCtD
Fludrocortisone—Asthenia—Cabazitaxel—prostate cancer	6.97e-05	0.0011	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Docetaxel—prostate cancer	6.96e-05	0.0011	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—prostate cancer	6.91e-05	0.00109	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—prostate cancer	6.8e-05	0.00107	CcSEcCtD
Fludrocortisone—Headache—Estradiol valerate/Dienogest—prostate cancer	6.8e-05	0.00107	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisone—prostate cancer	6.79e-05	0.00107	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Mitoxantrone—prostate cancer	6.79e-05	0.00107	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Capecitabine—prostate cancer	6.74e-05	0.00106	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Capecitabine—prostate cancer	6.7e-05	0.00106	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Docetaxel—prostate cancer	6.64e-05	0.00105	CcSEcCtD
Fludrocortisone—Urticaria—Bicalutamide—prostate cancer	6.62e-05	0.00104	CcSEcCtD
Fludrocortisone—Oesophagitis—Prednisone—prostate cancer	6.54e-05	0.00103	CcSEcCtD
Fludrocortisone—Vascular purpura—Capecitabine—prostate cancer	6.52e-05	0.00103	CcSEcCtD
Fludrocortisone—Haemoglobin—Estradiol—prostate cancer	6.5e-05	0.00102	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisone—prostate cancer	6.47e-05	0.00102	CcSEcCtD
Fludrocortisone—Haemorrhage—Estradiol—prostate cancer	6.47e-05	0.00102	CcSEcCtD
Fludrocortisone—Headache—Degarelix—prostate cancer	6.46e-05	0.00102	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—prostate cancer	6.39e-05	0.00101	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—prostate cancer	6.37e-05	0.001	CcSEcCtD
Fludrocortisone—Vertigo—Conjugated Estrogens—prostate cancer	6.32e-05	0.000996	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—prostate cancer	6.29e-05	0.000992	CcSEcCtD
Fludrocortisone—Convulsion—Goserelin—prostate cancer	6.15e-05	0.00097	CcSEcCtD
Fludrocortisone—Hypersensitivity—Bicalutamide—prostate cancer	6.14e-05	0.000968	CcSEcCtD
Fludrocortisone—Hypertension—Goserelin—prostate cancer	6.13e-05	0.000966	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	6.12e-05	0.0255	CrCbGaD
Fludrocortisone—Sweating increased—Etoposide—prostate cancer	6.1e-05	0.000961	CcSEcCtD
Fludrocortisone—Convulsion—Conjugated Estrogens—prostate cancer	6.1e-05	0.000961	CcSEcCtD
Fludrocortisone—Headache—Cabazitaxel—prostate cancer	6.09e-05	0.000959	CcSEcCtD
Fludrocortisone—Haemoglobin—Mitoxantrone—prostate cancer	6.06e-05	0.000955	CcSEcCtD
Fludrocortisone—Purpura—Capecitabine—prostate cancer	6.05e-05	0.000953	CcSEcCtD
Fludrocortisone—Myalgia—Goserelin—prostate cancer	6.05e-05	0.000953	CcSEcCtD
Fludrocortisone—Haemorrhage—Mitoxantrone—prostate cancer	6.03e-05	0.00095	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Prednisone—prostate cancer	6e-05	0.000945	CcSEcCtD
Fludrocortisone—Myalgia—Conjugated Estrogens—prostate cancer	5.99e-05	0.000944	CcSEcCtD
Fludrocortisone—Asthenia—Bicalutamide—prostate cancer	5.98e-05	0.000942	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisone—prostate cancer	5.97e-05	0.000941	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—prostate cancer	5.89e-05	0.000929	CcSEcCtD
Fludrocortisone—Vascular purpura—Prednisone—prostate cancer	5.81e-05	0.000915	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Goserelin—prostate cancer	5.8e-05	0.000914	CcSEcCtD
Fludrocortisone—Oedema—Goserelin—prostate cancer	5.8e-05	0.000914	CcSEcCtD
Fludrocortisone—Testosterone Propionate—CYP17A1—prostate cancer	5.77e-05	0.024	CrCbGaD
Fludrocortisone—Infection—Goserelin—prostate cancer	5.76e-05	0.000908	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	5.74e-05	0.000905	CcSEcCtD
Fludrocortisone—Oedema—Conjugated Estrogens—prostate cancer	5.74e-05	0.000905	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Prednisone—prostate cancer	5.73e-05	0.000903	CcSEcCtD
Fludrocortisone—Infection—Conjugated Estrogens—prostate cancer	5.71e-05	0.000899	CcSEcCtD
Fludrocortisone—Hydrocortisone—ANXA1—prostate cancer	5.66e-05	0.0236	CrCbGaD
Fludrocortisone—Injury—Prednisone—prostate cancer	5.65e-05	0.00089	CcSEcCtD
Fludrocortisone—Erythema—Estradiol—prostate cancer	5.63e-05	0.000887	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Goserelin—prostate cancer	5.6e-05	0.000883	CcSEcCtD
Fludrocortisone—Urticaria—Ethinyl Estradiol—prostate cancer	5.6e-05	0.000882	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Conjugated Estrogens—prostate cancer	5.55e-05	0.000875	CcSEcCtD
Fludrocortisone—Mood swings—Capecitabine—prostate cancer	5.52e-05	0.00087	CcSEcCtD
Fludrocortisone—Testosterone—CYP3A43—prostate cancer	5.51e-05	0.023	CrCbGaD
Fludrocortisone—Purpura—Prednisone—prostate cancer	5.39e-05	0.000849	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP3A43—prostate cancer	5.33e-05	0.0222	CrCbGaD
Fludrocortisone—Fluid retention—Epirubicin—prostate cancer	5.31e-05	0.000837	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Goserelin—prostate cancer	5.28e-05	0.000832	CcSEcCtD
Fludrocortisone—Erythema—Mitoxantrone—prostate cancer	5.25e-05	0.000827	CcSEcCtD
Fludrocortisone—Insomnia—Goserelin—prostate cancer	5.24e-05	0.000826	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	5.23e-05	0.000824	CcSEcCtD
Fludrocortisone—Headache—Bicalutamide—prostate cancer	5.22e-05	0.000823	CcSEcCtD
Fludrocortisone—Insomnia—Conjugated Estrogens—prostate cancer	5.19e-05	0.000818	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ethinyl Estradiol—prostate cancer	5.19e-05	0.000818	CcSEcCtD
Fludrocortisone—Muscular weakness—Capecitabine—prostate cancer	5.14e-05	0.00081	CcSEcCtD
Fludrocortisone—Oesophagitis—Epirubicin—prostate cancer	5.11e-05	0.000806	CcSEcCtD
Fludrocortisone—Affect lability—Prednisone—prostate cancer	5.11e-05	0.000806	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—prostate cancer	5.09e-05	0.000802	CcSEcCtD
Fludrocortisone—Abdominal distension—Capecitabine—prostate cancer	5.07e-05	0.000799	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—prostate cancer	5.06e-05	0.000797	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—prostate cancer	5.06e-05	0.000797	CcSEcCtD
Fludrocortisone—Vertigo—Estradiol—prostate cancer	5.06e-05	0.000797	CcSEcCtD
Fludrocortisone—Asthenia—Ethinyl Estradiol—prostate cancer	5.05e-05	0.000796	CcSEcCtD
Fludrocortisone—Mood swings—Prednisone—prostate cancer	4.92e-05	0.000775	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—prostate cancer	4.92e-05	0.000775	CcSEcCtD
Fludrocortisone—Sweating increased—Capecitabine—prostate cancer	4.91e-05	0.000774	CcSEcCtD
Fludrocortisone—Hypertension—Estradiol—prostate cancer	4.86e-05	0.000766	CcSEcCtD
Fludrocortisone—Myalgia—Estradiol—prostate cancer	4.79e-05	0.000755	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—prostate cancer	4.73e-05	0.000746	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—prostate cancer	4.71e-05	0.000742	CcSEcCtD
Fludrocortisone—Testosterone Propionate—COMT—prostate cancer	4.7e-05	0.0196	CrCbGaD
Fludrocortisone—Thrombophlebitis—Epirubicin—prostate cancer	4.69e-05	0.000739	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—prostate cancer	4.68e-05	0.000738	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—prostate cancer	4.68e-05	0.000738	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—prostate cancer	4.67e-05	0.000736	CcSEcCtD
Fludrocortisone—Urticaria—Goserelin—prostate cancer	4.61e-05	0.000726	CcSEcCtD
Fludrocortisone—Oedema—Estradiol—prostate cancer	4.6e-05	0.000724	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Estradiol—prostate cancer	4.6e-05	0.000724	CcSEcCtD
Fludrocortisone—Muscular weakness—Prednisone—prostate cancer	4.58e-05	0.000722	CcSEcCtD
Fludrocortisone—Infection—Estradiol—prostate cancer	4.57e-05	0.000719	CcSEcCtD
Fludrocortisone—Urticaria—Conjugated Estrogens—prostate cancer	4.56e-05	0.000719	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Capecitabine—prostate cancer	4.55e-05	0.000716	CcSEcCtD
Fludrocortisone—Convulsion—Mitoxantrone—prostate cancer	4.55e-05	0.000716	CcSEcCtD
Fludrocortisone—Vascular purpura—Epirubicin—prostate cancer	4.54e-05	0.000716	CcSEcCtD
Fludrocortisone—Hypertension—Mitoxantrone—prostate cancer	4.53e-05	0.000714	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisone—prostate cancer	4.52e-05	0.000712	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—prostate cancer	4.48e-05	0.000706	CcSEcCtD
Fludrocortisone—Myalgia—Mitoxantrone—prostate cancer	4.47e-05	0.000704	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Estradiol—prostate cancer	4.44e-05	0.0007	CcSEcCtD
Fludrocortisone—Headache—Ethinyl Estradiol—prostate cancer	4.41e-05	0.000695	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisone—prostate cancer	4.4e-05	0.000694	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisone—prostate cancer	4.37e-05	0.000689	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—prostate cancer	4.34e-05	0.000684	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—prostate cancer	4.32e-05	0.000681	CcSEcCtD
Fludrocortisone—Oedema—Mitoxantrone—prostate cancer	4.28e-05	0.000675	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mitoxantrone—prostate cancer	4.28e-05	0.000675	CcSEcCtD
Fludrocortisone—Hypersensitivity—Goserelin—prostate cancer	4.27e-05	0.000673	CcSEcCtD
Fludrocortisone—Infection—Mitoxantrone—prostate cancer	4.25e-05	0.00067	CcSEcCtD
Fludrocortisone—Hypersensitivity—Conjugated Estrogens—prostate cancer	4.23e-05	0.000667	CcSEcCtD
Fludrocortisone—Dexamethasone—ANXA1—prostate cancer	4.22e-05	0.0176	CrCbGaD
Fludrocortisone—Purpura—Epirubicin—prostate cancer	4.22e-05	0.000664	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—prostate cancer	4.2e-05	0.000662	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—prostate cancer	4.2e-05	0.000661	CcSEcCtD
Fludrocortisone—Haemoglobin—Docetaxel—prostate cancer	4.19e-05	0.00066	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Estradiol—prostate cancer	4.19e-05	0.00066	CcSEcCtD
Fludrocortisone—Haemorrhage—Docetaxel—prostate cancer	4.17e-05	0.000657	CcSEcCtD
Fludrocortisone—Asthenia—Goserelin—prostate cancer	4.16e-05	0.000655	CcSEcCtD
Fludrocortisone—Insomnia—Estradiol—prostate cancer	4.16e-05	0.000655	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—prostate cancer	4.15e-05	0.000653	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mitoxantrone—prostate cancer	4.14e-05	0.000652	CcSEcCtD
Fludrocortisone—Diflorasone—NR3C1—prostate cancer	4.14e-05	0.0172	CrCbGaD
Fludrocortisone—Desonide—NR3C1—prostate cancer	4.14e-05	0.0172	CrCbGaD
Fludrocortisone—Asthenia—Conjugated Estrogens—prostate cancer	4.12e-05	0.000649	CcSEcCtD
Fludrocortisone—Haemoglobin—Capecitabine—prostate cancer	4.05e-05	0.000639	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—prostate cancer	4.05e-05	0.000638	CcSEcCtD
Fludrocortisone—Desoximetasone—NR3C1—prostate cancer	4.04e-05	0.0168	CrCbGaD
Fludrocortisone—Haemorrhage—Capecitabine—prostate cancer	4.03e-05	0.000636	CcSEcCtD
Fludrocortisone—Affect lability—Epirubicin—prostate cancer	4e-05	0.00063	CcSEcCtD
Fludrocortisone—Loteprednol—NR3C1—prostate cancer	3.99e-05	0.0166	CrCbGaD
Fludrocortisone—Eplerenone—CYP3A5—prostate cancer	3.96e-05	0.0165	CrCbGaD
Fludrocortisone—Vertigo—Etoposide—prostate cancer	3.92e-05	0.000618	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	3.9e-05	0.000615	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—prostate cancer	3.9e-05	0.000615	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—prostate cancer	3.88e-05	0.000612	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—prostate cancer	3.85e-05	0.000606	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—prostate cancer	3.78e-05	0.000596	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—prostate cancer	3.77e-05	0.000594	CcSEcCtD
Fludrocortisone—Fluoxymesterone—SHBG—prostate cancer	3.7e-05	0.0154	CrCbGaD
Fludrocortisone—Affect lability—Doxorubicin—prostate cancer	3.7e-05	0.000583	CcSEcCtD
Fludrocortisone—Urticaria—Estradiol—prostate cancer	3.65e-05	0.000575	CcSEcCtD
Fludrocortisone—Headache—Goserelin—prostate cancer	3.63e-05	0.000572	CcSEcCtD
Fludrocortisone—Erythema—Docetaxel—prostate cancer	3.63e-05	0.000572	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisone—prostate cancer	3.61e-05	0.000569	CcSEcCtD
Fludrocortisone—Headache—Conjugated Estrogens—prostate cancer	3.6e-05	0.000567	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisone—prostate cancer	3.59e-05	0.000566	CcSEcCtD
Fludrocortisone—Muscular weakness—Epirubicin—prostate cancer	3.58e-05	0.000565	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Etoposide—prostate cancer	3.56e-05	0.000561	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—prostate cancer	3.56e-05	0.000561	CcSEcCtD
Fludrocortisone—Infection—Etoposide—prostate cancer	3.54e-05	0.000558	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—prostate cancer	3.53e-05	0.000557	CcSEcCtD
Fludrocortisone—Flurandrenolide—NR3C1—prostate cancer	3.53e-05	0.0147	CrCbGaD
Fludrocortisone—Erythema—Capecitabine—prostate cancer	3.51e-05	0.000553	CcSEcCtD
Fludrocortisone—Testosterone Propionate—AR—prostate cancer	3.5e-05	0.0146	CrCbGaD
Fludrocortisone—Hyperhidrosis—Etoposide—prostate cancer	3.44e-05	0.000543	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—prostate cancer	3.44e-05	0.000542	CcSEcCtD
Fludrocortisone—Hydrocortamate—NR3C1—prostate cancer	3.42e-05	0.0142	CrCbGaD
Fludrocortisone—Urticaria—Mitoxantrone—prostate cancer	3.4e-05	0.000536	CcSEcCtD
Fludrocortisone—Spironolactone—SHBG—prostate cancer	3.39e-05	0.0141	CrCbGaD
Fludrocortisone—Hypersensitivity—Estradiol—prostate cancer	3.39e-05	0.000534	CcSEcCtD
Fludrocortisone—Cortisone acetate—NR3C1—prostate cancer	3.37e-05	0.014	CrCbGaD
Fludrocortisone—Muscular weakness—Doxorubicin—prostate cancer	3.32e-05	0.000522	CcSEcCtD
Fludrocortisone—Asthenia—Estradiol—prostate cancer	3.3e-05	0.00052	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—prostate cancer	3.27e-05	0.000515	CcSEcCtD
Fludrocortisone—Fluoxymesterone—AR—prostate cancer	3.25e-05	0.0135	CrCbGaD
Fludrocortisone—Megestrol acetate—NR3C1—prostate cancer	3.24e-05	0.0135	CrCbGaD
Fludrocortisone—Pancreatitis—Doxorubicin—prostate cancer	3.19e-05	0.000502	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—SHBG—prostate cancer	3.18e-05	0.0132	CrCbGaD
Fludrocortisone—Amcinonide—NR3C1—prostate cancer	3.18e-05	0.0132	CrCbGaD
Fludrocortisone—Hyperglycaemia—Epirubicin—prostate cancer	3.17e-05	0.000499	CcSEcCtD
Fludrocortisone—Vertigo—Capecitabine—prostate cancer	3.16e-05	0.000497	CcSEcCtD
Fludrocortisone—Hypersensitivity—Mitoxantrone—prostate cancer	3.16e-05	0.000497	CcSEcCtD
Fludrocortisone—Convulsion—Docetaxel—prostate cancer	3.14e-05	0.000495	CcSEcCtD
Fludrocortisone—Hypertension—Docetaxel—prostate cancer	3.13e-05	0.000493	CcSEcCtD
Fludrocortisone—Erythema—Prednisone—prostate cancer	3.13e-05	0.000493	CcSEcCtD
Fludrocortisone—Myalgia—Docetaxel—prostate cancer	3.09e-05	0.000487	CcSEcCtD
Fludrocortisone—Asthenia—Mitoxantrone—prostate cancer	3.07e-05	0.000484	CcSEcCtD
Fludrocortisone—Hypertension—Capecitabine—prostate cancer	3.03e-05	0.000478	CcSEcCtD
Fludrocortisone—Mometasone—NR3C1—prostate cancer	3.02e-05	0.0126	CrCbGaD
Fludrocortisone—Methyltestosterone—SHBG—prostate cancer	2.99e-05	0.0125	CrCbGaD
Fludrocortisone—Myalgia—Capecitabine—prostate cancer	2.99e-05	0.000471	CcSEcCtD
Fludrocortisone—Spironolactone—AR—prostate cancer	2.97e-05	0.0124	CrCbGaD
Fludrocortisone—Oedema—Docetaxel—prostate cancer	2.96e-05	0.000466	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Docetaxel—prostate cancer	2.96e-05	0.000466	CcSEcCtD
Fludrocortisone—Infection—Docetaxel—prostate cancer	2.94e-05	0.000463	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Doxorubicin—prostate cancer	2.93e-05	0.000462	CcSEcCtD
Fludrocortisone—Headache—Estradiol—prostate cancer	2.88e-05	0.000454	CcSEcCtD
Fludrocortisone—Oedema—Capecitabine—prostate cancer	2.87e-05	0.000452	CcSEcCtD
Fludrocortisone—Infection—Capecitabine—prostate cancer	2.85e-05	0.000449	CcSEcCtD
Fludrocortisone—Urticaria—Etoposide—prostate cancer	2.83e-05	0.000446	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—prostate cancer	2.82e-05	0.000445	CcSEcCtD
Fludrocortisone—Vertigo—Prednisone—prostate cancer	2.81e-05	0.000443	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—prostate cancer	2.81e-05	0.000443	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—AR—prostate cancer	2.79e-05	0.0116	CrCbGaD
Fludrocortisone—Hyperhidrosis—Capecitabine—prostate cancer	2.77e-05	0.000437	CcSEcCtD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—prostate cancer	2.74e-05	0.0114	CrCbGaD
Fludrocortisone—Convulsion—Prednisone—prostate cancer	2.71e-05	0.000427	CcSEcCtD
Fludrocortisone—Hypertension—Prednisone—prostate cancer	2.7e-05	0.000426	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.7e-05	0.000425	CcSEcCtD
Fludrocortisone—Headache—Mitoxantrone—prostate cancer	2.68e-05	0.000423	CcSEcCtD
Fludrocortisone—Insomnia—Docetaxel—prostate cancer	2.68e-05	0.000422	CcSEcCtD
Fludrocortisone—Clobetasol propionate—NR3C1—prostate cancer	2.67e-05	0.0111	CrCbGaD
Fludrocortisone—Myalgia—Prednisone—prostate cancer	2.66e-05	0.00042	CcSEcCtD
Fludrocortisone—Progesterone—CYP17A1—prostate cancer	2.65e-05	0.011	CrCbGaD
Fludrocortisone—Hypersensitivity—Etoposide—prostate cancer	2.62e-05	0.000414	CcSEcCtD
Fludrocortisone—Methyltestosterone—AR—prostate cancer	2.62e-05	0.0109	CrCbGaD
Fludrocortisone—Haemoglobin—Doxorubicin—prostate cancer	2.61e-05	0.000412	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.61e-05	0.000411	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—prostate cancer	2.6e-05	0.00041	CcSEcCtD
Fludrocortisone—Insomnia—Capecitabine—prostate cancer	2.59e-05	0.000408	CcSEcCtD
Fludrocortisone—Fluorometholone—NR3C1—prostate cancer	2.57e-05	0.0107	CrCbGaD
Fludrocortisone—Asthenia—Etoposide—prostate cancer	2.56e-05	0.000403	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—prostate cancer	2.55e-05	0.000402	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisone—prostate cancer	2.55e-05	0.000402	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.55e-05	0.000765	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	2.55e-05	0.000764	CbGpPWpGaD
Fludrocortisone—Infection—Prednisone—prostate cancer	2.54e-05	0.0004	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	2.53e-05	0.000758	CbGpPWpGaD
Fludrocortisone—Progesterone—SLC22A3—prostate cancer	2.53e-05	0.0105	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—HIST1H2BG—prostate cancer	2.52e-05	0.000756	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—prostate cancer	2.52e-05	0.000756	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATM—prostate cancer	2.5e-05	0.000751	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—prostate cancer	2.5e-05	0.0104	CrCbGaD
Fludrocortisone—Methylprednisolone—NR3C1—prostate cancer	2.48e-05	0.0103	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—prostate cancer	2.48e-05	0.000745	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Prednisone—prostate cancer	2.47e-05	0.000389	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—prostate cancer	2.46e-05	0.000739	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—prostate cancer	2.46e-05	0.000737	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—prostate cancer	2.45e-05	0.000386	CcSEcCtD
Fludrocortisone—AR—Gene Expression—RPN2—prostate cancer	2.44e-05	0.000732	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.44e-05	0.000731	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HIST1H4H—prostate cancer	2.44e-05	0.000731	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NPPA—prostate cancer	2.44e-05	0.000731	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.44e-05	0.00073	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—prostate cancer	2.43e-05	0.00073	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARA—prostate cancer	2.43e-05	0.000729	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	2.43e-05	0.000727	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAD—prostate cancer	2.42e-05	0.000727	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP17A1—prostate cancer	2.42e-05	0.0101	CrCbGaD
Fludrocortisone—Clobetasol propionate—CYP1A1—prostate cancer	2.42e-05	0.0101	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—MED12—prostate cancer	2.4e-05	0.000719	CbGpPWpGaD
Fludrocortisone—Testosterone—SLC22A3—prostate cancer	2.39e-05	0.00994	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—prostate cancer	2.38e-05	0.000713	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—prostate cancer	2.37e-05	0.000711	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	2.37e-05	0.00071	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NPPA—prostate cancer	2.35e-05	0.000704	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARA—prostate cancer	2.34e-05	0.000703	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	2.34e-05	0.000701	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—prostate cancer	2.33e-05	0.000367	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—IRS1—prostate cancer	2.32e-05	0.000696	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	2.32e-05	0.000695	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ZNF160—prostate cancer	2.32e-05	0.000695	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SSR2—prostate cancer	2.32e-05	0.000695	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—BAZ2A—prostate cancer	2.32e-05	0.000695	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—QARS—prostate cancer	2.32e-05	0.000694	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MED12—prostate cancer	2.31e-05	0.000693	CbGpPWpGaD
Fludrocortisone—Insomnia—Prednisone—prostate cancer	2.31e-05	0.000364	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	2.29e-05	0.000687	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	2.29e-05	0.000685	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—prostate cancer	2.28e-05	0.000683	CbGpPWpGaD
Fludrocortisone—Urticaria—Capecitabine—prostate cancer	2.28e-05	0.000359	CcSEcCtD
Fludrocortisone—Prednisolone—CYP2A6—prostate cancer	2.27e-05	0.00945	CrCbGaD
Fludrocortisone—Erythema—Doxorubicin—prostate cancer	2.26e-05	0.000357	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—prostate cancer	2.26e-05	0.000678	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	2.26e-05	0.000678	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—SHBG—prostate cancer	2.25e-05	0.00938	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	2.24e-05	0.000671	CbGpPWpGaD
Fludrocortisone—Headache—Etoposide—prostate cancer	2.23e-05	0.000352	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—LEP—prostate cancer	2.22e-05	0.000667	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—prostate cancer	2.2e-05	0.00066	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—NR3C1—prostate cancer	2.2e-05	0.00917	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—prostate cancer	2.2e-05	0.00066	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—prostate cancer	2.2e-05	0.000346	CcSEcCtD
Fludrocortisone—Methyltestosterone—CYP19A1—prostate cancer	2.2e-05	0.00914	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	2.19e-05	0.000658	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	2.18e-05	0.000654	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Docetaxel—prostate cancer	2.18e-05	0.000344	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—prostate cancer	2.16e-05	0.000648	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—prostate cancer	2.15e-05	0.000644	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—prostate cancer	2.15e-05	0.00894	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	2.14e-05	0.000641	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.13e-05	0.000637	CbGpPWpGaD
Fludrocortisone—Asthenia—Docetaxel—prostate cancer	2.12e-05	0.000335	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—prostate cancer	2.12e-05	0.000636	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.12e-05	0.000636	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HNRNPH1—prostate cancer	2.12e-05	0.000635	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—prostate cancer	2.12e-05	0.000334	CcSEcCtD
Fludrocortisone—Betamethasone—CYP19A1—prostate cancer	2.12e-05	0.00882	CrCbGaD
Fludrocortisone—AR—Gene Expression—TBX5—prostate cancer	2.12e-05	0.000635	CbGpPWpGaD
Fludrocortisone—Hypertension—Epirubicin—prostate cancer	2.11e-05	0.000333	CcSEcCtD
Fludrocortisone—Hypersensitivity—Capecitabine—prostate cancer	2.11e-05	0.000333	CcSEcCtD
Fludrocortisone—Triamcinolone—NR3C1—prostate cancer	2.1e-05	0.00872	CrCbGaD
Fludrocortisone—Myalgia—Epirubicin—prostate cancer	2.08e-05	0.000328	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	2.08e-05	0.000624	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.08e-05	0.000622	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.06e-05	0.000617	CbGpPWpGaD
Fludrocortisone—Asthenia—Capecitabine—prostate cancer	2.06e-05	0.000324	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.04e-05	0.000612	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPS19—prostate cancer	2.04e-05	0.000611	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—prostate cancer	2.03e-05	0.00032	CcSEcCtD
Fludrocortisone—Urticaria—Prednisone—prostate cancer	2.03e-05	0.00032	CcSEcCtD
Fludrocortisone—Spironolactone—NR3C1—prostate cancer	2.02e-05	0.0084	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	2.01e-05	0.000602	CbGpPWpGaD
Fludrocortisone—Oedema—Epirubicin—prostate cancer	2e-05	0.000315	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—prostate cancer	2e-05	0.000315	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—IRS1—prostate cancer	1.98e-05	0.000595	CbGpPWpGaD
Fludrocortisone—Infection—Epirubicin—prostate cancer	1.98e-05	0.000313	CcSEcCtD
Fludrocortisone—Hydrocortamate—CYP3A4—prostate cancer	1.98e-05	0.00825	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NFIC—prostate cancer	1.97e-05	0.000591	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	1.97e-05	0.00059	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF3H—prostate cancer	1.97e-05	0.00059	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—prostate cancer	1.96e-05	0.000309	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—prostate cancer	1.95e-05	0.000308	CcSEcCtD
Fludrocortisone—Cortisone acetate—CYP3A4—prostate cancer	1.95e-05	0.00812	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—DNMT1—prostate cancer	1.95e-05	0.000584	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	1.95e-05	0.000583	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.95e-05	0.000583	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CREBBP—prostate cancer	1.93e-05	0.000579	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Epirubicin—prostate cancer	1.93e-05	0.000304	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—prostate cancer	1.93e-05	0.000578	CbGpPWpGaD
Fludrocortisone—Myalgia—Doxorubicin—prostate cancer	1.93e-05	0.000304	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	1.93e-05	0.000577	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.92e-05	0.000576	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOA2—prostate cancer	1.91e-05	0.000573	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—prostate cancer	1.9e-05	0.00057	CbGpPWpGaD
Fludrocortisone—Prednisone—NR3C1—prostate cancer	1.9e-05	0.00791	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	1.89e-05	0.00787	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—EZH2—prostate cancer	1.89e-05	0.000566	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Prednisone—prostate cancer	1.88e-05	0.000296	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—prostate cancer	1.88e-05	0.000562	CbGpPWpGaD
Fludrocortisone—Headache—Docetaxel—prostate cancer	1.85e-05	0.000292	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—RPN2—prostate cancer	1.85e-05	0.000555	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	1.85e-05	0.000555	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	1.85e-05	0.000555	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—prostate cancer	1.85e-05	0.000555	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MDM2—prostate cancer	1.85e-05	0.000554	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Doxorubicin—prostate cancer	1.85e-05	0.000291	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—prostate cancer	1.85e-05	0.000291	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PARP1—prostate cancer	1.85e-05	0.000554	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOA2—prostate cancer	1.84e-05	0.000552	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—prostate cancer	1.84e-05	0.000551	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—prostate cancer	1.84e-05	0.000289	CcSEcCtD
Fludrocortisone—Progesterone—SHBG—prostate cancer	1.84e-05	0.00764	CrCbGaD
Fludrocortisone—Progesterone—CYP1B1—prostate cancer	1.84e-05	0.00764	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	1.83e-05	0.000549	CbGpPWpGaD
Fludrocortisone—Asthenia—Prednisone—prostate cancer	1.83e-05	0.000289	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.82e-05	0.000546	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.82e-05	0.000287	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	1.81e-05	0.000543	CbGpPWpGaD
Fludrocortisone—Progesterone—SLC22A1—prostate cancer	1.81e-05	0.00754	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—prostate cancer	1.81e-05	0.000543	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	1.81e-05	0.000542	CbGpPWpGaD
Fludrocortisone—Insomnia—Epirubicin—prostate cancer	1.81e-05	0.000285	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.8e-05	0.000541	CbGpPWpGaD
Fludrocortisone—Headache—Capecitabine—prostate cancer	1.8e-05	0.000283	CcSEcCtD
Fludrocortisone—Hydrocortisone—CYP3A5—prostate cancer	1.79e-05	0.00747	CrCbGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—prostate cancer	1.79e-05	0.000281	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	1.78e-05	0.000534	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.78e-05	0.000534	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PARP1—prostate cancer	1.78e-05	0.000534	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—QARS—prostate cancer	1.76e-05	0.000527	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	1.75e-05	0.000525	CbGpPWpGaD
Fludrocortisone—Prednisolone—NR3C1—prostate cancer	1.75e-05	0.00729	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—prostate cancer	1.75e-05	0.000524	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HSPA1A—prostate cancer	1.75e-05	0.000524	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	1.75e-05	0.000523	CbGpPWpGaD
Fludrocortisone—Testosterone—SHBG—prostate cancer	1.73e-05	0.00722	CrCbGaD
Fludrocortisone—Testosterone—CYP1B1—prostate cancer	1.73e-05	0.00722	CrCbGaD
Fludrocortisone—Prednisone—CYP2C19—prostate cancer	1.73e-05	0.00721	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.72e-05	0.000516	CbGpPWpGaD
Fludrocortisone—Betamethasone—NR3C1—prostate cancer	1.72e-05	0.00715	CrCbGaD
Fludrocortisone—Eplerenone—CYP3A4—prostate cancer	1.71e-05	0.00713	CrCbGaD
Fludrocortisone—Testosterone—SLC22A1—prostate cancer	1.71e-05	0.00713	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—prostate cancer	1.69e-05	0.000505	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.68e-05	0.000505	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.68e-05	0.000265	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP1B1—prostate cancer	1.68e-05	0.00699	CrCbGaD
Fludrocortisone—Insomnia—Doxorubicin—prostate cancer	1.67e-05	0.000263	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—prostate cancer	1.65e-05	0.000496	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.64e-05	0.000491	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.61e-05	0.000484	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.61e-05	0.000483	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOA1—prostate cancer	1.61e-05	0.000483	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—prostate cancer	1.61e-05	0.000483	CbGpPWpGaD
Fludrocortisone—Progesterone—AR—prostate cancer	1.61e-05	0.0067	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.61e-05	0.000482	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TBX5—prostate cancer	1.61e-05	0.000482	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TET2—prostate cancer	1.6e-05	0.000481	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MBD2—prostate cancer	1.6e-05	0.000481	CbGpPWpGaD
Fludrocortisone—Headache—Prednisone—prostate cancer	1.6e-05	0.000252	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	1.59e-05	0.000478	CbGpPWpGaD
Fludrocortisone—Urticaria—Epirubicin—prostate cancer	1.59e-05	0.00025	CcSEcCtD
Fludrocortisone—AR—Gene Expression—RPL12—prostate cancer	1.57e-05	0.000472	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.55e-05	0.000466	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—prostate cancer	1.55e-05	0.000466	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.55e-05	0.000466	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOA1—prostate cancer	1.55e-05	0.000466	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AR—prostate cancer	1.54e-05	0.000463	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RXRA—prostate cancer	1.53e-05	0.000459	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.53e-05	0.000459	CbGpPWpGaD
Fludrocortisone—Testosterone—AR—prostate cancer	1.52e-05	0.00633	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.51e-05	0.000453	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF3H—prostate cancer	1.49e-05	0.000448	CbGpPWpGaD
Fludrocortisone—Fluorometholone—CYP3A4—prostate cancer	1.49e-05	0.0062	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.49e-05	0.000446	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—prostate cancer	1.48e-05	0.000444	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—RXRA—prostate cancer	1.48e-05	0.000443	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.48e-05	0.000443	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.47e-05	0.000442	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—prostate cancer	1.47e-05	0.000232	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—prostate cancer	1.47e-05	0.000231	CcSEcCtD
Fludrocortisone—Progesterone—CYP3A5—prostate cancer	1.46e-05	0.00609	CrCbGaD
Fludrocortisone—AR—Gene Expression—EIF3A—prostate cancer	1.44e-05	0.000433	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—prostate cancer	1.44e-05	0.000433	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—CYP3A4—prostate cancer	1.44e-05	0.006	CrCbGaD
Fludrocortisone—Asthenia—Epirubicin—prostate cancer	1.43e-05	0.000226	CcSEcCtD
Fludrocortisone—Progesterone—CYP2A6—prostate cancer	1.41e-05	0.00589	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—prostate cancer	1.41e-05	0.000422	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	1.4e-05	0.000421	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.4e-05	0.000419	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.4e-05	0.000419	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—VDR—prostate cancer	1.39e-05	0.000416	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP3A5—prostate cancer	1.38e-05	0.00575	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.37e-05	0.000411	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.37e-05	0.00041	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—prostate cancer	1.37e-05	0.00041	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.36e-05	0.000409	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.36e-05	0.000409	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—prostate cancer	1.36e-05	0.000214	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.35e-05	0.000405	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—NR3C1—prostate cancer	1.34e-05	0.00558	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—prostate cancer	1.34e-05	0.000401	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP3A5—prostate cancer	1.34e-05	0.00557	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.33e-05	0.0004	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.33e-05	0.000399	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—prostate cancer	1.33e-05	0.000209	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.32e-05	0.000396	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.31e-05	0.000393	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2A6—prostate cancer	1.29e-05	0.00539	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.29e-05	0.000387	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.29e-05	0.000387	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.29e-05	0.000386	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.28e-05	0.000383	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.28e-05	0.000383	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—prostate cancer	1.27e-05	0.0053	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—ERCC2—prostate cancer	1.27e-05	0.000381	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.26e-05	0.000379	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—prostate cancer	1.25e-05	0.000197	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—prostate cancer	1.25e-05	0.000375	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—prostate cancer	1.24e-05	0.00516	CrCbGaD
Fludrocortisone—Dexamethasone—CYP19A1—prostate cancer	1.23e-05	0.00513	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.23e-05	0.000368	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.22e-05	0.000367	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MBD2—prostate cancer	1.22e-05	0.000365	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TET2—prostate cancer	1.22e-05	0.000365	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT3B—prostate cancer	1.22e-05	0.000365	CbGpPWpGaD
Fludrocortisone—Triamcinolone—CYP3A4—prostate cancer	1.21e-05	0.00506	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—prostate cancer	1.2e-05	0.000361	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.2e-05	0.00036	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.19e-05	0.000358	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL12—prostate cancer	1.19e-05	0.000358	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.19e-05	0.000358	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL10—prostate cancer	1.19e-05	0.000358	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—prostate cancer	1.19e-05	0.00495	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.19e-05	0.000356	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.18e-05	0.000353	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.18e-05	0.000353	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HIST1H2BG—prostate cancer	1.17e-05	0.000351	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARA—prostate cancer	1.17e-05	0.000351	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.16e-05	0.000349	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—prostate cancer	1.16e-05	0.000182	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—prostate cancer	1.15e-05	0.000344	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NPPA—prostate cancer	1.13e-05	0.000339	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HIST1H4H—prostate cancer	1.13e-05	0.000339	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.13e-05	0.000339	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARA—prostate cancer	1.13e-05	0.000338	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.12e-05	0.000336	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.12e-05	0.000335	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MED12—prostate cancer	1.11e-05	0.000333	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.11e-05	0.000332	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.1e-05	0.00033	CbGpPWpGaD
Fludrocortisone—Prednisone—CYP3A4—prostate cancer	1.1e-05	0.00459	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.1e-05	0.000329	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.1e-05	0.000328	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	1.1e-05	0.00456	CrCbGaD
Fludrocortisone—Progesterone—NR3C1—prostate cancer	1.09e-05	0.00454	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.07e-05	0.000321	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.07e-05	0.00032	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	1.06e-05	0.000318	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—prostate cancer	1.06e-05	0.000318	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.05e-05	0.000314	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.04e-05	0.000311	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP3A4—prostate cancer	1.03e-05	0.00429	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—prostate cancer	1.02e-05	0.000306	CbGpPWpGaD
Fludrocortisone—Prednisolone—CYP3A4—prostate cancer	1.02e-05	0.00423	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.01e-05	0.000304	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—prostate cancer	9.98e-06	0.00416	CrCbGaD
Fludrocortisone—Progesterone—CYP2C19—prostate cancer	9.95e-06	0.00414	CrCbGaD
Fludrocortisone—Betamethasone—CYP3A4—prostate cancer	9.95e-06	0.00414	CrCbGaD
Fludrocortisone—Progesterone—CYP1A1—prostate cancer	9.91e-06	0.00413	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	9.89e-06	0.000296	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—prostate cancer	9.74e-06	0.00406	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	9.46e-06	0.000284	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPS19—prostate cancer	9.46e-06	0.000284	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP2C19—prostate cancer	9.4e-06	0.00392	CrCbGaD
Fludrocortisone—Testosterone—CYP1A1—prostate cancer	9.37e-06	0.0039	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—CREBBP—prostate cancer	9.3e-06	0.000279	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT3B—prostate cancer	9.23e-06	0.000277	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—prostate cancer	9.19e-06	0.00383	CrCbGaD
Fludrocortisone—Dexamethasone—CYP2C19—prostate cancer	9.1e-06	0.00379	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	9.09e-06	0.000272	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—prostate cancer	9.06e-06	0.00377	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—RPL10—prostate cancer	9.05e-06	0.000271	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT1—prostate cancer	9.04e-06	0.000271	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CREBBP—prostate cancer	8.96e-06	0.000269	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	8.96e-06	0.000269	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	8.88e-06	0.000266	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOA2—prostate cancer	8.87e-06	0.000266	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	8.79e-06	0.000264	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EZH2—prostate cancer	8.75e-06	0.000262	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—prostate cancer	8.72e-06	0.000261	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	8.58e-06	0.000257	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NPPA—prostate cancer	8.58e-06	0.000257	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PARP1—prostate cancer	8.57e-06	0.000257	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	8.56e-06	0.000257	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MED12—prostate cancer	8.44e-06	0.000253	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	8.4e-06	0.000252	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—prostate cancer	8.3e-06	0.000249	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA1A—prostate cancer	8.11e-06	0.000243	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—prostate cancer	8.11e-06	0.000243	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—CYP3A4—prostate cancer	7.77e-06	0.00323	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	7.76e-06	0.000232	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOA1—prostate cancer	7.48e-06	0.000224	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	7.42e-06	0.000223	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	7.18e-06	0.000215	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPS19—prostate cancer	7.18e-06	0.000215	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RXRA—prostate cancer	7.11e-06	0.000213	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT1—prostate cancer	6.86e-06	0.000206	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	6.8e-06	0.000204	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOA2—prostate cancer	6.73e-06	0.000202	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EZH2—prostate cancer	6.64e-06	0.000199	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SIRT1—prostate cancer	6.54e-06	0.000196	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PARP1—prostate cancer	6.5e-06	0.000195	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—VDR—prostate cancer	6.44e-06	0.000193	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	6.37e-06	0.000191	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP3A4—prostate cancer	6.33e-06	0.00263	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA1A—prostate cancer	6.16e-06	0.000185	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—prostate cancer	6.16e-06	0.000185	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP3A4—prostate cancer	5.98e-06	0.00249	CrCbGaD
Fludrocortisone—AR—Gene Expression—ERCC2—prostate cancer	5.89e-06	0.000177	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR3C1—prostate cancer	5.8e-06	0.000174	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP3A4—prostate cancer	5.79e-06	0.00241	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NCOA1—prostate cancer	5.67e-06	0.00017	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—prostate cancer	5.67e-06	0.00236	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—prostate cancer	5.52e-06	0.000165	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AR—prostate cancer	5.44e-06	0.000163	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARA—prostate cancer	5.43e-06	0.000163	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RXRA—prostate cancer	5.4e-06	0.000162	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—prostate cancer	5.32e-06	0.000159	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—prostate cancer	4.96e-06	0.000149	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—prostate cancer	4.92e-06	0.000148	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—VDR—prostate cancer	4.89e-06	0.000146	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ERCC2—prostate cancer	4.47e-06	0.000134	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CREBBP—prostate cancer	4.31e-06	0.000129	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARA—prostate cancer	4.12e-06	0.000124	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—prostate cancer	4.05e-06	0.000121	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	4.03e-06	0.000121	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—prostate cancer	3.83e-06	0.000115	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—prostate cancer	3.73e-06	0.000112	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CREBBP—prostate cancer	3.27e-06	9.81e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.07e-06	9.2e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—prostate cancer	2.56e-06	7.67e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—prostate cancer	1.94e-06	5.82e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—prostate cancer	1.78e-06	5.32e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—prostate cancer	1.35e-06	4.04e-05	CbGpPWpGaD
